Human peripheral blood mononuclear cells are analyzed for preproenkephalin gene expression and peptide processing.
Introduction
Neuropeptides represent one group of regulatory mediators that coordinate interactions between the nervous system and cells ofthe immune system (1) . This has been demonstrated for peptides that are present in peripheral nerves (2) but also for the endogenous opioids (3) . The mature pentapeptide met-enkephalin caused functional and phenotypic changes in T lymphocytes. Wybran et al. first demonstrated an increase in active T rosette formation (4) . A series of subsequent studies showed that met-enkephalin influences specific immunity through the stimulation of human T cell migration (5), augmentation of peripheral blood lymphocyte proliferation (6) , and through inhibition of primary and secondary antibody synthesis in vitro (7, 8) . In addition, enkephalins were shown to stimulate nonspecific effector functions such as chemotaxis (9) , superoxide production (10), antibody-dependent cellular cytotoxicity (ADCC) (10) , and NK cell function (11) . The discovery of opioid receptors on T lymphocytes and monocytes provided a structural basis for their ability to modulate cell functions (3) . Depending on its cellular origin, met-enkephalin can influence the immune system in an endocrine, paracrine, or autocrine way. The major sites ofmet-enkephalin production in the neuroendocrine system are brain, spinal cord and sympathic ganglia, and the adrenal medulla (12) . The finding that cells ofthe immune system may be capable of producing met-enkephalin provides the basis for paracrine or autocrine effects. The expression of preproenkephalin A mRNA in an activated mouse T-helper cell line at high levels comparable to those oftypical T cell specific products such as interleukin-2, indicated that immune cells may be significant producers of enkephalin-like substances (13) . Preproenkephalin mRNA was also found in activated murine B cells from spleen, bone marrow, lymph node, and in murine macrophages (14, 15) .
Although these results clearly document that the preproenkephalin gene can be transcribed in cells of the immune system, it is not known which products are generated from the precursor protein proenkephalin A. It has been suggested that T helper cells only secrete intermediate higher molecular weight enkephalin-like peptides, and that processing to metenkephalin does not take place (16) . The peptides secreted by monocytes have not been analyzed. This study was designed to investigate which cells among human peripheral blood mononuclear cells express the preproenkephalin A mRNA, how this is regulated, and which peptides are produced. Proenkephalin A mRNA was found in activated peripheral blood T cells and monocytes, but the two cell types are characterized by differential processing of the propeptide.
lated from mononuclear cell suspensions by adherence to plastic (Falcon Flasks, Becton Dickinson Co., Lincoln Park, NJ) at 370C in RPMI 1640 medium, supplemented with 10% autologous plasma.
Culture conditions. PBMC and peripheral blood T cells were cultured with PHA (1% vol/vol) (Difco) and IL-2 (Cetus Corp., Emeryville, CA) in RPMI 1640 with 5% heat inactivated FBS at a cell concentration of 1 x 106 cells/ml per well in 24-well tissue culture plates (Costar Corp., Cambridge, MA). Macrophage plates were incubated in a humidified atmosphere containing 5% CO2 at 370C for up to 3 d. Analysis ofthe time kinetics showed that maximal secretion of met-enkephalin was reached by 24 h and this time point was thus studied in all subsequent experiments. Monocytes were resuspended in RPMI 1640 supplemented with 5% heat inactivated FBS at 106/ml and stimulated with PMA (1-5 ng/ml) or LPS (100 pg-10 Mg/ml).
Immunohistochemistry. Cells were recovered from the tissue culture plates, washed in PBS, and cytocentrifuge preparations ofmononuclear cells were prepared in a Shandon-Elliott centrifuge (Shandon Southern, Astmoor, Runcorn, Cheshire, England) (500-700 rpm for 5 min) from 150 ,d of the washed cell suspension (106/ml). Monocytes were cultured and stained on tissue culture chamber slides (Nunc, Inc., Naperville, IL). The cells were fixed in a mixture of 99% ethanol and 1% acetic acid for 20 min at 4IC. Monocytes were treated with a blocking serum (preimmune goat serum, 1/400 dilution) for 20 min (50 Al).
The cells were incubated at 40C in humidified chambers for 2 h with rabbit antibody to met-enkephalin (Incstar, Stillwater, MN) at dilutions of 1/100-1/500. This rabbit antiserum was raised against met-enkephalin conjugated to bovine thyroglobulin. The slides were then washed by dipping 20 times in cold PBS. Secondary biotinylated antibody (Vector Laboratories, Burlingame, CA; 1/300, 50 ul) and the avidin-peroxidase complex (15 gl/ml PBS, 50 gl) were applied for 45 min each. The slides were developed with freshly prepared substrate (3-amino, 9-ethyl carbazole; Biomeda Corp., Foster City, CA). The cells were counterstained with hematoxylin.
Immunostaining oftissue. Lymphoid tissues were obtained at surgery and snap frozen in liquid nitrogen. Frozen tissue sections (5 Mm) were incubated with a blocking serum (preimmune goat serum, 1/400 dilution) for 30 min. The blocking agent was removed and the slides were incubated for 16-24 h with rabbit antibody to met-enkephalin (Incstar) at dilutions of 1/100-1/500. Incubation with biotinylated secondary antibody and avidin-peroxidase were performed as described above.
Radioimmunoassay. Met-enkephalin in the conditioned media from PBMC and isolated subsets was quantified by RIA (Incstar). The cross-reactivity ofthe antibody used in this assay with other products of the preproenkephalin gene or other neuropeptides is < 3%, except for peptide F (22%) (17) .
Culture supernatants (l-ml aliquots) were acidified with 100 Ml of 1 mM HCO and extracted with ODS silica columns (Immunonuclear Corp.). The columns were washed with 20 ml of 4% acetic acid, eluted with 4 ml 99.8% methanol, and the eluates were lyophilized. Duplicate samples of dried eluates were resuspended in bovine serum albuminphosphate buffer before the assay. In some experiments, the dried eluates were resuspended in Tris-buffer (pH 8.5) with 0.2% bovine serum albumin and digested with L-l-Tosylamide-2-phenylethyl chloro-methyl ketone (TPCK)'-treated trypsin (I Mtg trypsin/200 Ml) for 16 h at 37°C, followed by treatment with carboxypeptidase B (0.1 Mg/ 200 Ml) for 2 h at 37°C. To inactivate the enzyme the supernatants were treated for 20 min at 90°C. The samples were then tested in the met-enkephalin radioimmunoassay.
Met-enkephalin concentrations in the culture supernatants were calculated on the basis of a standard curve using synthetic met-enkephalin (10 pg-2.5 ng) that was included in each assay. mega Corp.). The probe was recovered by gel filtration (Centri-sep columns; Princeton Separations Inc., Adelphia, NJ). The specific activity was -2 X I0O cpm/,g template.
Northern blot hybridization. PBMC, T cells, and monocytes were isolated, purified, and cultured as described above. Total RNA was extracted by the single step Guanidinium Thiocyanate-Phenol-Chloroform method (19) , analyzed by gel electrophoresis, blotted onto nylon filters, and cross-linked with UV light for 5 min each side. The blots were prehybridized in 50% Formamide, 6x SSC, 0.5% SDS, 0.1% Tween 20, 100 gg tRNA/ml for 15 min at 650C. The prehybridization mixture was replaced with fresh solution containing 106 cpm/ml of probe. Hybridization was performed overnight at 650C and followed by washes in lx SSC (2 X 30 min) and 0.1X SSC (2 x 30 min) at 650C in the presence of 0.1% SDS. The filters were dried and exposed to Kodak XAR film at -70'C. Met-enkephalin secretion by PBMC. Met-enkephalin was measured in supernatants of cultured PBMC by using a specific RIA (Fig. 1 A) . Supernatants of nonactivated PBMC contained low levels (< 100 pg/ml) of met-enkephalin. After activation with PHA, a maximal fourfold increase in peptide production was observed. This was related to an increase in met-enkephalin production per cell because the cell numbers were only 11±3% higher in PHA-activated cultures. To determine which cells among PBMC produce met-enkephalin, monocytes and T cells were separated. Monocytes were activated with PMA (1 ng/ml) and supernatants were collected after 24 h. Spontaneous secretion was higher as compared with the same number of unfractionated PBMC. After activation with PMA, monocytes secreted increased levels of met-enkephalin ( Fig. 1 B) . Although the absolute levels of met-enkephalin varied in monocyte cultures from different donors, in each of the 11 different normal donors tested, PMA increased met-enkephalin release (mean increase 5.06±3.56-fold, P < 0.009). LPS, a second monocyte activator, also induced met-enkephalin secretion (data not shown).
In purified populations of T lymphocytes there was only very low spontaneous secretion of met-enkephalin. Even after incubation in the presence of PHA and IL-2, a combination of stimuli that induces maximal proliferation of the cells, we did not detect an increase in peptide release (Fig. 1 C) .
Detection of met-enkephalin immunoreactivity in PBMC. To consolidate these findings on peptide secretion by monocytes with detection of intracellular met-enkephalin and to exclude the possibility that lymphocytes may synthesize, but not secrete the peptide in culture, immunohistochemistry was performed on peripheral blood monocytes and T cells. Monocytes showed cytoplasmatic staining after PMA activation (Fig. 2 A) .
Maximal expression ofmet-enkephalin immunoreactive material was seen after 24 h. At that time point, up to 90% of the activated cells were positive. In nonstimulated monocyte cultures less than 15% of the cells showed cytoplasmic staining with a lower intensity (Fig. 2 B) . Specificity of the staining was demonstrated by blocking the antibody with pentapeptide metenkephalin (Fig. 2 C) and by negative staining with normal rabbit serum (Fig. 2 D) . Under these conditions, no positive cytoplasmatic staining was seen. Furthermore, preincubation of the antiserum with leu-enkephalin did not abrogate the staining (Fig. 2 E) . Expression ofpreproenkephalin mRNA in PBMC. To investigate whether the absence ofmet-enkephalin immunoreactive material in activated T cells was due to incomplete processing ofthe prepropeptide or due to absent transcription or translation, RNA was isolated from unseparated PBMC, T cells, and monocytes and analyzed by Northern blotting (Fig. 3) . Activated PBMC showed a strong hybridization signal at 1.4 kb, which is consistent with the size of mature preproenkephalin mRNA. Maximal expression in unfactionated PBMC was seen at 24 h. Purified monocytes express this mRNA very early (2 h) and as with the titers of secreted peptides there was also donor variability in mRNA levels (Fig. 3 A) . Experiments with purified T cells (Fig. 3 B) showed that these cells also express the preproenkephalin RNA by 2 h and that maximal expression after stimulation occurs by 24 h. The 24 h signal in PBMC was thus probably due to met-enkephalin expression by T cells. Possible interactions between monocytes and T cells may contribute to higher levels of RNA and changes in kinetics in unseparated PBMC as compared with the purified subpopula- (20) . Supernatants from PHA/ x y-IL-2-activated T cells were assayed for met-enkephalin before ase and after digestion with trypsin and carboxypeptidase B. As shown earlier, the untreated T cell supernatants contained only very low levels of met-enkephalin. After enzymatic digestion of aliquots from the same T cell conditioned media, met-enkephalin was detected in concentrations up to 400 pg/ml (Fig. 4 A) .
Protease treatment of nonconditioned culture media resulted in the detection of80 pg/ml ofmet-enkephalin which probably originated from FBS that was present in the culture media. Similar experiments with monocyte conditioned media showed that these cells also secrete precursor molecules (Fig. 4 B). Precursor (Fig. 5) . These results indicate that monocytes store and release detectable levels of met-enkephalin precursors and that the in- 
Detection of met-enkephalin immunoreactive cells in vivo.
A.
Having shown that monocytes produce met-enkephalin in vi- (22) . The lack of staining in T cells indicates that these cells only produce proenkephalin A or process the propeptide to larger molecular weight intermediates that are not recognized by the antiserum. Similar differences that are at least in part related to the extent ofintracellular processing were found in the met-enkephalin immunoreactive material secreted by monocytes and T cells. Conditioned media from monocytes contains peptides that are either completely processed met-enkephalin and/or peptide F. In addition, other precursor molecules are secreted by monocytes and are detectable as met-enkephalin immunoreactive material after in vitro hydrolysis. These precursors include the noncross-reactive peptides I, B, and E, and proenkephalin A. Secretion of these precursors is also increased after monocyte activation. In contrast to monocytes, there was no met-enkephalin immunoreactivity in native conditioned media from T cells. However, treatment of T cell supernatants with trypsin and carboxypeptidase B generated high levels of met-enkephalin immunoreactive material. This in vitro treatment has been shown to result in the production of the pentapeptide (20) , but it is possible that incompletely processed peptide F may also contribute to the immunoreactivity detected in this study (17) . Studies on murine helper T cell lines have shown the production predominantly of high molecular weight material (16) . The presence ofthe precursor molecule in the conditioned media from nonstimulated monocytes can be explained by storage and release of constitutively produced precursor. The levels of peptide in supernatants of nonstimulated monocytes is not influenced by cyclohexamide and actinomycin-D, also suggesting intracytoplasmic storage ofthe peptide. The levels of precursor molecules secreted by monocytes were higher in monocytes than in T cells. This is consistent with the function of monocytes as secretory cells and may also be related to the use of monocyte activators that stimulate secretory function and proliferative agents for T cells.
Differences in proenkephalin precursors as reported here for monocytes and T cells have previously been described between neural and adrenal tissues. The profile of enkephalin products from monocytes is more closely related to that found in neural tissues that generate lower molecular weight products, while that of T lymphocytes resembles more adrenal cells which secrete larger amounts of higher molecular weight precursor proteins (12) . In this context it is of interest that the distribution of met-enkephalin immunoreactive cells in human spleen is almost identical to the distribution of cells that express endorphins in murine spleen. Furthermore, splenic macrophages express the mRNA for proopiomelanocortin and process the polyvalent precursor protein to mature opioid-active peptides. In contrast, splenic lymphocytes do not express these peptides (23, 24) . Collectively these observations may indicate that monocytes, but not lymphocytes, are able to process the large molecular weight precursors of neuropeptides. This may be related to the presence of processing enzymes in monocytes but not in T cells. Detailed analysis of this notion will be possible once met-enkephalin processing enzymes have been completely characterized.
The precursor molecules secreted by T cells may represent a source of peptide that is more stable and rapidly activated. Relatively high levels ofmet-enkephalin reactivity are found in plasma (17) . In addition to the nervous system, adrenal gland, and the gut (12, 25) , it is conceivable that cells ofthe immune system contribute to this circulating pool. Alternatively, the incompletely processed precursor may be functionally active.
This has already been shown for some of the precursor forms that have very high affinity for opioid receptors (26) . The (6- 8, 10, 1 1) . In addition, met-enkephalin is a chemotactic factor for T lymphocytes (5) and monocytes (9) . This may indicate that met-enkephalin produced at sites of inflammation promotes the influx of immune cells. In agreement with this concept are the recent findings by Saland and co-workers (27) , that endogenous opoids such as a-and fl-endorphin and met-enkephalin, administered to the lateral ventricle of rats, caused an influx of leukocytes.
It is also possible that enkephalins produced by cells of the immune system act on opioid receptors expressed in the nervous system or modulate functions of connective tissue cells (28) . Met-enkephalin produced by cells of the immune system may, thus, not only modulate immune functions but contribute to the regulation of local and systemic aspects of host defense responses.
